triamcinolone acetonide

Modality

small molecule

Mechanism

—

Targets

—

Storage

—

Approved

atopic dermatitis — FDA · alopecia areata — FDA

In trial

prurigo nodularis, psoriasis, atopic dermatitis, alopecia areata, vitiligo, hidradenitis suppurativa

Sources

Last verified

2026-04-23

No curated MOA diagram yet. See lib/moa-data.ts for the shape; add an entry keyed by triamcinolone acetonide.

Formulations

0.025% / 0.1% / 0.5% cream / ointment / lotion10 mg/mL + 40 mg/mL injectable suspension (intralesional)